• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gracell Biotechnologies Inc. - American Depositary Shares (NQ:GRCL)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 10.22 (49)
Ask (Size) 10.41 (10)
Prev. Close 10.25
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Gracell Biotechnologies Acquisition Completed
February 22, 2024
From Gracell Biotechnologies Inc.
Via GlobeNewswire
News headline image
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
February 20, 2024
From Gracell Biotechnologies Inc.
Via GlobeNewswire

Performance

More News

Read More
Gracell Biotechnologies Inc. (NASDAQ: GRCL) is a Stock Spotlight on 2/7
February 07, 2024
Via Investor Brand Network
News headline image
Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies ↗
December 26, 2023
Via Benzinga
News headline image
Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets ↗
February 03, 2024
Via Talk Markets
News headline image
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
January 29, 2024
From Gracell Biotechnologies Inc.
Via GlobeNewswire
News headline image
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment ↗
January 23, 2024
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
AstraZeneca: Rebound in 2024 with double-digit earnings growth
January 11, 2024
Via MarketBeat
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs ↗
January 05, 2024
Via Benzinga
News headline image
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗
January 05, 2024
Via Investor's Business Daily
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
January 04, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
GRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Gracell Biotechnologies Inc. - GRCL
December 31, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal ↗
December 31, 2023
Via Talk Markets
News headline image
Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review ↗
December 29, 2023
Via Investor's Business Daily
Topics Stocks
News headline image
Investor Sentiment Improves; Dow Jumps Over 150 Points ↗
December 27, 2023
Via Benzinga
Topics Stocks
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
December 26, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher ↗
December 26, 2023
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
December 26, 2023
Via Benzinga
News headline image
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
December 26, 2023
Via Benzinga
News headline image
Crude Oil Rises Over 3%; US Home Prices Increase In October ↗
December 26, 2023
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
December 26, 2023
Via Benzinga
News headline image
Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket ↗
December 26, 2023
Via Benzinga
News headline image
US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs ↗
December 26, 2023
Via Benzinga

Frequently Asked Questions

Is Gracell Biotechnologies Inc. - American Depositary Shares publicly traded?
Yes, Gracell Biotechnologies Inc. - American Depositary Shares is publicly traded.
What exchange does Gracell Biotechnologies Inc. - American Depositary Shares trade on?
Gracell Biotechnologies Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Gracell Biotechnologies Inc. - American Depositary Shares?
The ticker symbol for Gracell Biotechnologies Inc. - American Depositary Shares is GRCL on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap